Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

Choquette Denis; Bessette Louis; Haraoui Boulos; Pelletier Jean-Pierre; Raynauld Jean-Pierre; Villeneuve Edith; Massicotte Frederic; Remillard Marie-Anais; Sauvageau Diane; Coupal Louis

首页> 外文期刊>The Journal of rheumatology >Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

【24h】

Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

机译：从RHUMADATA（R）登记处对强直性脊柱炎患者使用单一疗法抗TNF药物：阿达木单抗，依那西普和英夫利昔单抗的8年比较疗效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2015年第7期|共1页
作者
Choquette Denis; Bessette Louis; Haraoui Boulos; Pelletier Jean-Pierre; Raynauld Jean-Pierre; Villeneuve Edith; Massicotte Frederic; Remillard Marie-Anais; Sauvageau Diane; Coupal Louis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab [J] . Choquette Denis, Bessette Louis, Haraoui Boulos, The Journal of rheumatology . 2015,第7期

机译：从RHUMADATA（R）登记处对强直性脊柱炎患者使用单一疗法抗TNF药物：阿达木单抗，依那西普和英夫利昔单抗的8年比较疗效
2. Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the RHUMADATA (R) Clinical Database and Registry [J] . Coupal Louis, Haraoui Boulos, Bessette Louis, The Journal of rheumatology . 2015,第7期

机译：比较类风湿关节炎患者的阿巴西普与阿达木单抗，依那西普和英夫利昔单抗作为一线或二线药物。 RHUMADATA（R）临床数据库和注册中心的经验
3. Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous Anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from the Provincial Electronic Database and Registry Rhumadata [J] . Choquette Denis, Bessette Louis, Haraoui Boulos, The Journal of rheumatology . 2016,第6期

机译：类风湿性关节炎患者中曾使用过6年Tocilizumab且以前曾接受过抗TNF药物治疗：与省电子数据库和注册的Rhumadata中的Adalimumab和Etanercept进行比较
4. Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry [O] . Proton Rahman, Michael Starr, Derek Haaland, 2020

机译：来自加拿大前瞻性观测登记处的长期脊柱癣菌和Golimalab患者的长期效果和安全性
5. Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival [O] . Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari, 2014

机译：生物学希拉特曲调患者中英昔单抗，阿达木单抗和依赖替替尼替替替替尼替代的比较效果及存活：低缓解率和5年药物存活率

Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

著录项

引文网络

相似文献

相关主题

期刊订阅